Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127901351 | 12790135 | 1 | I | 20160921 | 20160928 | 20160928 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-078106 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127901351 | 12790135 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, QD | U | U | HH0086 | 21986 | 100 | MG | FILM-COATED TABLET | QD | |||
| 127901351 | 12790135 | 2 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Unknown | U | 0 | TABLET | |||||||||
| 127901351 | 12790135 | 3 | C | CARTIA /00002701/ | ASPIRIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127901351 | 12790135 | 1 | Chronic myeloid leukaemia |
| 127901351 | 12790135 | 2 | Product used for unknown indication |
| 127901351 | 12790135 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127901351 | 12790135 | OT |
| 127901351 | 12790135 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127901351 | 12790135 | Fluid retention | |
| 127901351 | 12790135 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |